Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Total Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2020     100,016,559        
Beginning balance at Dec. 31, 2020 $ 36,216 $ 36,216 $ 10 $ 243,484 $ 0 $ (207,278) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (125,874) (125,874)       (125,874)  
Business combination, net of redemptions and equity issuance costs and PIPE financing, net (in shares)     41,249,985        
Business combination, net of redemptions and equity issuance costs and PIPE financing, net 300,745 300,745 $ 4 300,741      
Issuance of common stock upon exercise of common stock warrants (in shares)     7,177,885        
Issuance of common stock upon exercise of common stock warrants, net 82,546 82,546 $ 1 82,545      
Issuance of common stock upon exercise of stock options (in shares)     2,180,168        
Issuance of common stock upon exercise of stock options 62 62   62      
Issuance of Series D convertible preferred stock upon exercise of warrants (in shares)     2,020,034        
Issuance of Series D convertible preferred stock upon exercise of warrants 20,877 20,877   20,877      
RSUs vested, net of shares withheld for taxes (in shares)     61,015        
Early exercised stock options vested 111 111   111      
Stock-based compensation 11,434 11,434   11,434      
Repurchase of unvested restricted common stock (in shares)     (433,359)        
Ending balance (in shares) at Jan. 02, 2022     152,272,287        
Ending balance at Jan. 02, 2022 $ 326,117 326,117 $ 15 659,254 0 (333,152) 0
Beginning balance (in shares) at Jul. 13, 2021 563,316,738            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Acquisition of Routejade (in shares) 28,749,985            
Ending balance (in shares) at Jul. 14, 2021 145,245,628            
Beginning balance (in shares) at Jan. 02, 2022     152,272,287        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (51,622) (51,622)       (51,622)  
Issuance of common stock upon exercise of common stock warrants (in shares)     4,126,466        
Issuance of common stock upon exercise of common stock warrants, net 47,452 47,452   47,452      
Issuance of common stock upon exercise of stock options (in shares)     381,497        
Issuance of common stock upon exercise of stock options 2,379 2,379   2,379      
Issuance of common stock under employee stock purchase plan (in shares)     229,249        
Issuance of common stock under employee stock purchase plan 1,900 1,900   1,900      
RSUs vested, net of shares withheld for taxes (in shares)     621,179        
RSUs vested, net of shares withheld for taxes (587) (587)   (587)      
Early exercised stock options vested 122 122   122      
Stock-based compensation $ 30,666 30,666   30,666      
Repurchase of unvested restricted common stock (in shares)     (168,876)        
Ending balance (in shares) at Jan. 01, 2023 157,461,802   157,461,802        
Ending balance at Jan. 01, 2023 $ 356,427 356,427 $ 15 741,186 0 (384,774) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (214,132) (214,071)       (214,071) (61)
Issuance of common stock upon exercise of stock options (in shares) 1,482,808   1,482,808        
Issuance of common stock upon exercise of stock options $ 11,928 11,928   11,928      
Issuance of common stock under employee stock purchase plan (in shares)     285,847        
Issuance of common stock under employee stock purchase plan 2,350 2,350   2,350      
RSUs vested, net of shares withheld for taxes (in shares)     2,655,170        
RSUs vested, net of shares withheld for taxes (3,930) (3,930) $ 1 (3,931)      
Early exercised stock options vested 128 128   128      
Purchase of Capped Calls (17,250) (17,250)   (17,250)      
Stock-based compensation 69,848 69,848   69,848      
Repurchase of unvested restricted common stock (in shares)     (416,833)        
Acquisition of Routejade (in shares)     5,923,521        
Issuance of common stock for the Routejade Acquisition 55,796 52,779 $ 1 52,778     3,017
Other comprehensive loss, net $ (62) (62)     (62)    
Ending balance (in shares) at Dec. 31, 2023 167,392,315   167,392,315        
Ending balance at Dec. 31, 2023 $ 261,103 $ 258,147 $ 17 $ 857,037 $ (62) $ (598,845) $ 2,956